ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2019
Emerging safety issues in alemtuzumab-treated MS patients.
Joep Killestein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2019
Joep Killestein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.